# Ann H. Partridge

Source: https://onco.cc/people/ann-partridge/  
OnCo record `ann-partridge` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Ann Partridge led the POSITIVE trial showing women can safely pause hormone therapy to have a baby.

## Summary

Ann H. Partridge is Vice Chair of Medical Oncology and Director of the Program for Young Adults with Breast Cancer at Dana-Farber Brigham Cancer Center. She is known for leading the POSITIVE trial, which showed that women can safely pause endocrine therapy to have a baby, and for the Young Women's Breast Cancer Study. Her selected paper reports interrupting endocrine therapy to attempt pregnancy after breast cancer. She now directs Dana-Farber's adult survivorship and young women's breast cancer programmes, with a focus on fertility and life after cancer.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Vice Chair of Medical Oncology; Director, Program for Young Adults with Breast Cancer
- Specialisms: Young women's breast cancer; Survivorship; Fertility after cancer

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Ann_Partridge
- Dana-Farber profile: https://www.dana-farber.org/find-a-doctor/ann-h-partridge
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Partridge%20AH%5BAuthor%5D

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- technologies: [Endocrine therapy (SERMs, AIs, SERDs)](https://onco.cc/technologies/endocrine-therapy/)
- institutions: [Breast Cancer Research Foundation](https://onco.cc/institutions/bcrf/), [Dana-Farber Brigham Cancer Center](https://onco.cc/institutions/dana-farber/)

---
JSON: https://onco.cc/api/v1/entities/ann-partridge.json